Dual targeting of EphA2 and FAK in ovarian carcinoma

EphA2 gene silencing has been shown to result in anti-tumor efficacy. Here we considered whether silencing additional targets downstream of EphA2 would further enhance the therapeutic effect. EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposome...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Shahzad, Mian M.K., Lu, Chunhua, Lee, Jeong-Won, Stone, Rebecca L., Mitra, Rahul, Mangala, Lingegowda S., Lu, Yiling, Baggerly, Keith A., Danes, Christopher G., Nick, Alpa M., Halder, Jyotsnabaran, Kim, Hye-Sun, Vivas-Mejia, Pablo, Landen, Charles N., Lopez-Berestein, Gabriel, Coleman, Robert L., Sood, Anil K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2748749/
https://ncbi.nlm.nih.gov/pubmed/19395869
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller